Design, production and immunomodulatory potency of a novel allergen bioparticle.

Design, production and immunomodulatory potency of a novel allergen bioparticle.

Allergen immunotherapy (AIT) is the only disease-modifying treatment with evidence for sustained efficacy. However, it is poorly developed compared to symptomatic drugs. The main reasons come from treatment duration implying monthly injections during 3 to 5 years or daily sublingual use, and the ris...

Full description

Bibliographic Details
Main Authors: Véronique Gomord, Virginie Stordeur, Anne-Catherine Fitchette, Elizabeth D Fixman, Guy Tropper, Lorna Garnier, Réjean Desgagnes, Sébastien Viel, Julie Couillard, Guillaume Beauverger, Sylvain Trepout, Brian J Ward, Ronald van Ree, Loic Faye, Louis-P Vézina
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0242867

Internet

https://doi.org/10.1371/journal.pone.0242867

Similar Items